Objective: Ureaplasma spp. in the maternal genitourinary tract is increasingly known to cause preterm labor, spontaneous abortion, chorioamnionitis and adverse neonatal outcomes. However, con trover sies still remain regarding whether or not to treat it aggressively. The aim of this study was to evaluate the effects of antenatal azithromycin (AZ) for Ureaplasma urealyticum (UU) infection on neonatal com plications in preterm infants. Methods: Retrospective singlecenter casecontrol study of preterm babies delivered at <32 weeks' of gestation age (GA) between 2010 and 2014 were conducted. Cases were defined as infants with complete maternal AZ treatment when UU was confirmed and controls were without UU. Cases were matched with controls by birth year, GA, and birth weight. Subgroup analysis according to GA (23 +0 28 +6 weeks' and 29 +0 32 +6 weeks') were done as well. Results: Of 169 cases identified 51 with untreated or incompletely treated mother, 26 died or trans ferred, and four with incomplete chart were excluded; thus 88 preterm infants were matched to 88 controls. Incidence of bronchopulmonary dysplasia (BPD) and early sepsis were same in both group; however, in very preterm infants between 23 +0 to 28 +6 weeks' GA, incidence of moderatetosevere BPD was significantly higher in cases (42% vs. 16%, P=0.022) and incidence of sepsis was significantly lower (8% vs. 26%, P=0.033). Conclusion: Maternal UU was associated with moderatetosevere BPD even though AZ treatment was done. Early sepsis was significantly less developed with prenatal antibiotics at ≤28 weeks' GA. Hence selective antenatal azithromycin therapy of UU is still needed for improving neonatal out comes.
Introduction
Ureaplasma urealyticum (UU) is one of the frequently isolated microorganisms from the amniotic fluid and infected placentas. 1, 2 Although UU is isolated from the vagina in 40% to 80% of sexually active asymptomatic women as a commensal organism, it can cause pre term delivery, spontaneous abortion or miscarriages, chorioamnionitis, neonatal morbidity, and/or perinatal death. 3, 4 UU can be transmitted vertically from the mother to the fetus in utero, or to the newborn infant at delivery. 5, 6 Intrauterine UU infection is found to alter lung development, prolong inflammatory res ponse and increase fibrotic reaction in animals. 7 In one study, the risk of moderateto severe bronchopulmonary dysplasia (BPD) development showed a 7.9fold increase in mecha nically ventilated infants being ventilated for any reason with positive UU tracheal aspirate, 8 and a twofold increased risk for necrotizing enterocolitis (NEC) in preterm infants with respiratory UU infection. 9 UU colonization had been found in the blood, cere bro spinal fluid, and brain tissue and the risk of severe intraventricular hemorrhage was www.e-kjp.org Perinatology increased to 2.5fold higher in infants with positive serum UU colonization. 10 Since genital mycoplasmas including UU are unable to pro duce cell walls, betalactams, vancomycin, sulfonamides, or trimethoprim is ineffective. 2 UU is generally susceptible to certain antibiotics that interfere with protein synthesis. 2, 11 There are some studies that have evaluated the use of eryth ro mycin in preterm infants with UU colonization and erythro mycin was once known as a standard antibiotic for preterm premature rupture of membrane (PPROM) treatment. 1214 Azithromycin (AZ) is an expandedspectrum macrolide anti biotic that is sup posed to have better tissue penetration than erythromycin; hence, it can be an alternative antibiotic. 11, 15 Recent studies in rhesus monkeys suggested that antenatal multipledose AZ therapy could mitigate pregnancyasso ciated complications. 16 However, not many studies about the effectiveness of antenatal AZ treatment have been done, and whether or not AZ is effec tive is still being debated. Thus, the aim of this study was to demonstrate the clinical effects of antenatal AZ treatment of UUcolonized mothers on neonatal morbidity.
Methods

Study subjects
All preterm infants who were admitted to Hallym University Medical Center between January 2010 and December 2014 were eligible for this study. Those without maternal UU results, those who were transferred to or from other institutes for any reason, those without complete medical charts, or those who died before 28 days of life were excluded. The final included infants were those born at ≤32 weeks' of gestational age (GA), since most of the nearterm infants who were considered for inclusion did not need intensive care. Then infants with com plete antenatal AZ treatment of UUcolonized mothers (cases) were matched with controls by birth year, GA, and birth weight (±100 g). This retrospective singlecenter casecontrol study was approved by the institutional review boards of our facility.
Urealyticum confirmation and azithromycin treatment
UU samples from the maternal lower genitalia area were ob tained from those who were admitted for any reason, via by vaginal swabs during a physical examination. MYCOFAST ® Evolution 2 (International Microbio, Signes, France) was used for culture analysis, and polymerase chain reaction (PCR) was done as well. If the interval between admission and delivery was more than one week, the microbiological examinations were re peated. To obtain a sufficient amount of sample, all of the procedures were performed twice. UUpositive was de fined as with at least one result was being positive, and then AZ was administrated for treatment. Complete antenatal azithro mycin therapy was defined when oral AZ of 500 mg/day was admini strated for three consecutive days before delivery.
Definitions of parameters
The maternal and clinical variables compared between the cases and controls were GA, birth weight, preterm labor, PPROM, antenatal steroid administration, chorioamnionitis, sur factant use, BPD, patent ductus arteriosus (PDA), retinopathy of prematurity (ROP), early sepsis, NEC, and cranial sonography abnormality.
PPROM was defined as the rupture of membranes ≥24 hours before delivery. Clinical chorioamnionitis was identified in the mother with fever (≥37.8°C) and two or more of the following: Perinatology surfactant use (56% vs. 60%, P=0.541) and BPD (35% vs. 43%, P=0.280). Other parameters including PDA with treatment, ROP with laser, NEC, early sepsis, abnormal cranial sonography showed no significant differences as well. Significant difference was found regarding higher incidence of moderatetosevere BPD in cases (18% vs. 7%, P=0.038) ( Table 2) .
Since gestational and/or birth weight is one of the major fac tors for neonatal morbidities, we divided the study populations into subgroups regarding GA; specifically, infants with 29 +0 32 +6 weeks' GA (cases n=50 vs. controls n=50, respectively) and infants with 23 +0 28 +6 weeks' GA (cases n=38 vs. controls n=38, respectively). In a subgroup analysis, no significant dif ferences were shown with respect to surfactant use, BPD, PDA with treatment, ROP with laser, NEC, and cranial sono graphy abnormality between cases and controls. None of the infants with ≥29 weeks' GA had moderatetosevere BPD and ROP with laser.
In infants of 23 +0 28 +6 weeks' GA, the incidence of mode ratetosevere BPD was higher in cases (42%) than in controls (16%) (P=0.022) and the incidence of early sepsis was signi ficantly lower in cases (8%) than in controls (26%) (P=0.033).
Data analysis
Statistical analysis was performed using Student's ttest for normally distributed data and the chisquared test or Fisher's exact test for comparisons between frequencies. All statistical analysis was performed with SPSS (version 22, IBM, Armonk, NY, USA). Data were reported in the format of mean±standard deviation or number (%). Statistical significance was accepted at P<0.05.
Results
Overall characteristics of study population
During the study period, 169 preterm infants of ≤32 weeks'
GA were diagnosed as having maternal UU colonization. Of then, 51 cases were excluded due to incomplete or untreated mother at first. Of the remaining 118 cases 26 died or trans ferred during their neonatal hospitalization and another four had to be excluded due to incomplete chart. From the cohort of 26 mo thers, four were transferred to a different department (two for PDA surgery and two for treatment of hydrocephalus). The demographics and clinical characteristics of cases and controls are depictured in Table 1 . There were no significant differences regarding primipara, PPROM, preterm labor, ante natal steroids, and chorioamnionitis between cases and con trols of maternal variables. HC which was confirmed by patho logist after delivery showed no difference between two groups.
For neonatal characteristics between cases and control, we found no significant differences between Apgar scores at 1 min ute and 5 minutes, length of stay, duration of use of ventila tion, and duration of oxygen supplement (Table 1 ).
Neonatal morbidities according to the gestational age at birth
There were no significant differences in the incidence of Many studies demonstrated that the isolation of UU from the placenta or the lower genital tract during pregnancy plays a causal role in the process of intrauterine inflammation and infectiondriven preterm labor. 10, 18, 19 Hence, as Acosta et al. 16 said, preterm delivery caused by intrauterine infection can be potentially "preventable" and that maternal antibiotics could be administrated to prevent and treat intrauterine infection.
Their study on nonhuman primates showed that repeated IV doses of maternal AZ could be accumulated sufficient enough to clear Ureaplasma parvum (U. parvum) from the amniotic fluid. Another study in an ovine model by Miura et al. 19 also showed that maternal antenatal azithromycin therapy of either IV only or IV+ intraamniotic AZ effectively eradicated marco lidesen sitive U. parvum form the amniotic fluid. However, in our study, there was no significant differences in the incidence of preterm labor between two groups (86% vs. 77%, P=0.171).
This find ing might explain the ineffectiveness of antenatal treat ment of AZ and further investigations are needed.
Meanwhile, the frequency of perinatal transmission such as vertical transmission or intrauterine infection from UUcolo nized mothers was reported to be 58% for preterm infants 9 and 22% to 55% for fullterm infants. 20 UU isolation in the pre term respiratory tract was associated with neonatal pneumo nia, severe respiratory failure, and BPD. 16 Since three indepen dent groups first reported the association between lower respiratory tract UU colonization in very preterm infants and the develop ment of chronic lung disease in 1988, numerous studies about UU colonization and BPD have been documented with different results. 4, 21, 22 One study by Sung et al. 8 The associations between respiratory tract UU colonization and BPD have been confirmed by many studies, even though gestational age appeared to be a major confounder. 2325 Recently, studies about the effects of macrolide antibiotics including erythromycin and/or AZ given either prophylactically or therapeutically to reduce BPD or other neonatal morbidities are reported with different results. 7, 12, 26 A systematic review Perinatology with metaanalysis showed promising results of prophylactic AZ therapy in terms of a significant reduction in BPD, 7 while a very recent casecontrol study demonstrated no significant therapeutic effect of erythromycin on pulmonary short and longterm morbidity. 27 Nevertheless, studies about antenatal macrolide treatment on neonatal morbidities are sparse. In our study about antenatal AZ treatment, it showed that overall BPD incidence seemed to be similar between cases and controls;
however, there was no effect on reducing the development of moderatetosevere BPD in certain gestational age ranges.
Hence, the administration of single antibiotics to eradicate intrauterine infection may not be sufficient as other studies have reported, and additional antiinflammatory therapy or selec tive treatments might be needed. 19, 28, 29 Risk factors of BPD include not only sepsis, but also RDS, pulmonary interstitial emphysema, short gestational period, patent ductus arteriosus, increased pulmonary arterial pressure, and high peak inspiratory press ure. Several studies reported that UU infection causes bron chopulmonary dysplasia in premature babies. One of the hypo theses state that phospholipase A2 produced by UU suppresses the production of pulmonary surfactant. 30, 31 More detailed mechanism discovered hitherto explains that the generation of bronchopulmonary dysplasia is due to an increased secretion of proinflammatory cytokines (such as IL6 and TNFα) by phagocytes when UU colony formation occurs. 32 In this study, within mild BPD patients, the prevalence of bronchopulmonary dysplasia between the UU infection group (treated) and the control group was not significantly different. On the other hand, moderate and severe BPD group showed higher prevalence of bronchopulmonary dysplasia in mothers with less gestational age from the UU infection group. We have previously mention ed as the limitation of our study that Az treatment may be an insufficient stand alone treatment as mentioned in other stud ies. This allows us to speculate that additional antiinflamma tory or selective treatments are needed. Furthermore, in the group of premature babies with very short gestational age, normal lung development is even more difficult. The babies are put into the environment with continuous damage against al veolarization from lengthened ventilation and oxygen therap ies. In addition, the babies are affected by UU infection from the mothers. To gether, the prevalence is significantly higher in severe BPD group compared to the control group.
In our findings, one unique result was that the incidence of early sepsis was significantly low with antenatal AZ treatment in infants of sepsis was' GA (8% vs. 26%, P=0.033) although the total incidence of early sepsis in preterm babies ≤32 weeks'
GA between cases and controls were similar (9% vs. 15%, P= 0.353). In general, infected amniotic fluid and placenta from UU infected mother can infect the newborn. 5, 33 This ver tical infec tion can cause sepsis in the newborn, and infected amniotic fluid also allows potential congenital pneumonia, sep sis from syste mic infection, and CNS infection. 34 If the newborn is likely to be premature due to UU infection, he or she is more prone to sep sis caused by other bacteria. This is because premature babies have suppressed immune system and mucosal barrier function, and therefore are more prone to infection. Sepsis has multiple risk factors including low birth weight, maternal infection, cho rio amnionitis, premature rupture of membranes, and fetal hypo xia. 22 However, the fact that premature babies less than 28
weekold from mothers who received Az treat ment had signi ficantly lower prevalence of early sepsis com pared to the other groups indicate potential effects of antenatal UU treat ment.
Waites et al. 35 descried that even though infection in the blood stream of neonates had not been documented, there were the potential ability of UU to produce invasive disease. Since studies about the effects of antenatal AZ on early sepsis are rare, our results could suggest a promising way to reduce early sepsis in preterm infants.
There are number of limitation in our study. First, variable antenatal antibiotics other than AZ were used, and we could not control for them since this was a retrospective study. However, this study was a single center study; hence, similar antibiotics were used for study populations apart from AZ. Second, a followup UU culture and/or PCR were not implemented to con firm UUnegative conversion. Hence, a large scaled ran domized control study is urgently needed to prove these study results. Thirdly, although lateonset sepsis is known as one of the risk factors of BPD, it was not considered in our study.
Currently, our center is performing the examinations of prema www.e-kjp.org Perinatology consent. This led to insufficient number of samples for the power of the study. In order to assess the effects of antenatal AZ treatment in the mothers on premature birthswhich is the main question of the studywe have performed indepth follow up of UU condition in the premature babies. We had to collect more data in order to perform multivariate analysis considering the effects between groups when UU was negative and when UU was positive by detailing followup of UU condition in the premature babies. With the data we have collected thus far, we could not deduce any significant result. Additional data needs to be collected in future, and we plan on addressing this issue as a main question of our next study.
Furthermore, the limitation of this study is the lack of com parative analysis of neonatal complications in the premature babies between the two subgroups of mothers: the group of UU negative mothers in the reexamination after antenatal Az treatment, and the group of UU positive mothers in the reex amination.
In addition to all premature babies born between 23 +0 28 +6
week were given oxygen and ventilator treatment, and prema ture babies born between 29 +0 32 +6 week were given ventilator treatment with varying ventilation therapies for different bab ies. It is difficult to create subgroups as the therapies (such as high frequency ventilation, positive pressurelimited, time cy cle me thod, nasal continuous positive airway pressure, high flow na sal cannula, and etc.) change frequently according to the con ditions and weaning stages of the babies. One possible asse ssment is to use the first ventilation therapy after the birth as the sole variable, create subgroups, and perform multiple re gres sion analysis in order to assess whether or not UU affects the severity of BPD. However, due to the limited number of cases, this issue should be addressed in the future.
In conclusion, maternal UU colonization was associated with the development of BPD, especially moderatetosevere BPD, even though antenatal AZ treatment was done. Early sepsis was significantly less developed with the administration of an tenatal antibiotics in ially mod' GA. Hence, selective antenatal azithromycin therapy of UU is still needed for improving neo natal outcomes.
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